Smart Safety Syringes Maker Sharps Technology Closes Initial Public Offering

Medical device company Sharps Technology announced the closing of its initial public offering at $4.25 on Friday. The company has patented, best-in-class, single use smart safety syringe products. The common stock and warrants began trading on The Nasdaq Capital Market under the symbols “STSS” and “STSSW,” respectively. Sharps Provensa™ is their premier line of smart safety syringes. The firm says that offer solutions to global healthcare crises such as the 1-2 billion syringe shortage forecasted by the World Health Organization (WHO) … Continue reading “Smart Safety Syringes Maker Sharps Technology Closes Initial Public Offering”

US Weekly IPO and SPAC Monitor: Cybersecurity, Cannabidiol and Psychedelics, Cancer and Pregnancy Therapeutics.

Coming into Year end the IPO market is winding down. This week we have just four IPOs scheduled to raise around $50 million for the week. Cerberus Cyber Sentinel (CISO), Incannex Healthcare (IXHL), Intensity Therapeutics (INTS) and Nuvo Group (NUVO) are expected to debut this week. Cerberus Cyber Sentinel (CISO) Cerberus Cyber Sentinel (CISO) based in Scottsdale, Arizona plans to raise $10 million priced at $5 for a $631 million market cap. The company provides a range of cybersecurity consulting and related services, … Continue reading “US Weekly IPO and SPAC Monitor: Cybersecurity, Cannabidiol and Psychedelics, Cancer and Pregnancy Therapeutics.”

US Weekly IPO and SPAC Monitor : IoT Cloud Solutions Developer Samsara Leads

Coming into Year end the IPO market is winding down. This week we have four IPOs scheduled to raise $814 million for the week. IoT solutions developer (IOT) Samsara, CNS biotech Bionomics (BNOX), Fresh Vine Wine (VINE) and Satellite developer Sidus Space (SIDU) are all expected to debut this week. IoT solutions developer Samsara (IOT) Samsara plans to raise $753 million at an $11.6 billion market cap. Samsara is a developer of end-to-end Internet of Things solutions for businesses and provides a cloud-based platform. The … Continue reading “US Weekly IPO and SPAC Monitor : IoT Cloud Solutions Developer Samsara Leads”

US Weekly IPO and SPAC Monitor : Buffett-backed Brazil’s Nubank Lead

Following the Thanksgiving lull the IPO market is expected to pick up with four IPOs scheduled to raise $3.7 billion for the week. Chicago Atlantic Real Estate Finance (REFI) Cloud infrastructure platform HashiCorp (HCP) Austin Gold (AUST) and Buffett-backed Nu Holdings (NU) debut. Cloud infrastructure platform HashiCorp (HCP) Plans to raise $1.1 billion at a $14.0 billion market cap. This VC-backed company provides a suite of solutions that standardize and automate the provisioning, securing, connecting, and running of cloud infrastructure at scale. While it has demonstrated rapid growth and … Continue reading “US Weekly IPO and SPAC Monitor : Buffett-backed Brazil’s Nubank Lead”

F.D.A. Antimicrobial Drugs Panel Endorse Merck’s Covid Pill Molnupiravir For High Risk Adults.

The Food and Drug Administration Antimicrobial Drugs Advisory Committee Meeting voted on Tuesday to recommend authorizing the molnupiravir Covid pill from Merck for high-risk adults. It would be the first in a new class of antiviral drugs that could work against a wide range of variants, including Omicron. Molnupiravir has been shown to modestly reduce the risk of hospitalization and death, predominantly from the Delta, Mu and Gamma variants. The expert panel recommended it for Covid patients who are older … Continue reading “F.D.A. Antimicrobial Drugs Panel Endorse Merck’s Covid Pill Molnupiravir For High Risk Adults.”

US Weekly IPO and SPAC Monitor : Just One IPO Biotech Nuvectis Pharma

Following Thanksgiving week we have just one IPO due. Phase 1-ready biotech Nuvectis Pharma ($NVCT) plans to raise $30 million at a $160 million market cap.  Be aware there is still a chance that a handful of SPACs will price during the week. Phase 1-ready biotech Nuvectis Pharma ($NVCT) plans to raise $30 million at a $160 million market cap. The company is initially focused the development of innovative precision medicines for the treatment of serious unmet medical needs in oncology. Nuvectis is currently … Continue reading “US Weekly IPO and SPAC Monitor : Just One IPO Biotech Nuvectis Pharma”